cetus corporation one first biotechnology established berkeley california conducted operations nearby emeryville merging chiron corporation part novartis developed several significant pharmaceutical drugs well revolutionary dna amplification technique cetus founded ronald e cape peter farley nobelist donald glaser early efforts involved automated methods select industrial microorganisms could produce greater amounts chemical feedstocks antibiotics vaccine components late however three new revolutionary techniques developed recombinant dna monoclonal antibodies gene expression foundations biotechnology industry order enter new fields cetus raised million initial public offering ipo largest ipo date first large development project conjunction triton biosciences successful cloning expression modification production betainterferon unfortunately resultant protein live expectations broadspectrum anticancer drug much later approved use treat symptoms multiple product sold name betaseron companys flagship product important modifier immune system early intense competition clone gene underway among cetus genentech immunex japanese researcher tadatsugu taniguchi taniguchi first cetus created proprietary recombinant version collaborated steven rosenberg begin clinical drug showed promising effects treating renal cancer also significant side effects patients us food drug administration fda refused approve drug clinical use asking additional wasnt two years later cetus sold approved distributed name proleukin company also broad effort research develop techniques dna diagnostics collaborations made perkinelmer diagnostic instruments kodak commercial diagnostic kits technique polymerase chain reaction pcr dna amplification conceived kary mullis technique widely used dna research forensics genetic disease diagnostics inventor received nobel prize one awarded research performed biotechnology company delay fda approval created major funding crisis cetus spending considerable fraction investments produce test companys ceo resigned six weeks later patent rights pcr process sold hoffmanla roche losses continued company sold chiron chiron continued development finally approved fda chiron also collected scattered rights production betainterferon approved clinical use httpsenwikipediaorgwikicetuscorporation